Type II 5-alpha-reductase
Isoenzyme that converts testosterone into dihydrotestosterone (DHT) and the main target of finasteride, which has around 100 times greater affinity for it than for the type I isoenzyme.
Institutional endorsement by Clínica Evolution
This entry is for information. Your case requires an individual medical assessment.